This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Nell V et al. (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis [10.1136/ard.2005.035691]
Smolen JS et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate without or with concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum, in press
Grigor C et al. (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364: 263–269
Smolen JS et al. (2005) Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 52: 1020–1030
Fathman CG et al. (2005) An array of possibilities for the study of autoimmunity. Nature 435: 605–611
Valk PJ et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350: 1617–1628
Hueber W et al. (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 52: 2645–2655
Molenaar ET et al. (2004) Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 50: 36–42
Smolen JS and Aletaha D (2004) Patients with rheumatoid arthritis in clinical care. Ann Rheum Dis 63: 221–225
Aletaha D et al. (2005) Functional limitation in rheumatoid arthritis: how much is reversible? Arthritis Rheum, in press
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Smolen, J., Aletaha, D. Challenges of predicting treatment response in patients with rheumatoid arthritis. Nat Rev Rheumatol 1, 62–63 (2005). https://doi.org/10.1038/ncprheum0050
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0050
This article is cited by
-
Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
Arthritis Research & Therapy (2020)
-
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
Arthritis Research & Therapy (2018)
-
Yin-yang and Zheng: Exported from Chinese medicine
Chinese Journal of Integrative Medicine (2014)